title: The neurologist's dilemma: MS is a grey matter disease that standard clinical and MRI measures cannot assess adequately--no.
authors.affiliation: Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy. m.filippi@hsr.it
authors.forename: M
authors.initials: M
authors.lastname: Filippi
authors.forename: M A
authors.initials: MA
authors.lastname: Rocca
mesh_terms: D001284:Atrophy; D001921:Brain / Q000473:pathology* / Q000503:physiopathology; D004185:Disability Evaluation; D006801:Humans; D008279:Magnetic Resonance Imaging; D009103:Multiple Sclerosis / Q000175:diagnosis* / Q000473:pathology / Q000503:physiopathology; D011237:Predictive Value of Tests; D011379:Prognosis; D015203:Reproducibility of Results; D012720:Severity of Illness Index